United States · FDA National Drug Code directory
YARTEMLEA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 62225-300_48da2b07-9b4c-7b5f-e063-6394a90a7b62
- Product NDC
- 62225-300
- Form
- INJECTION
- Composition / generic term
- narsoplimab
- Labeler
- Omeros Corporation
- Marketing category
- BLA
- Marketing start / end (source format)
- 20260120
- Source listing expiry
- 20271231
Source-listed ingredients
- NARSOPLIMAB — 370 mg/2mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 CARTON (62225-300-00) / 2 mL in 1 VIAL · 62225-300-00
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →